Reaction

Calcinosis reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 2,209 reports · 36 co-occurring drugs

As of the last recalculation, Calcinosis appears in 2,209 FAERS reports alongside 36 co-occurring drug terms. The strongest observed disproportionality signal is ASFOTASE ALFA (PRR 70.0).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Asfotase Alfa	72	70.0	70.5
Calcitriol Capsules 0.25 Mcg	31	14.8	14.8
Calcitriol Capsules 0.5 Mcg	31	14.8	14.8
Calcitriol	31	14.6	14.6
Epoetin Alfa	16	12.8	12.8
Teriparatide	117	10.3	10.3
Calcium Gluconate	13	10.2	10.2
Diltiazem Hydrochloride Extended-Release Tablets	12	10.0	10.0
Cortisone Acetate	12	9.2	9.2
Phenobarbital	14	9.2	9.2
Icodextrin, Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride	27	8.3	8.3
Nitrofurantoin	13	7.5	7.5
Paricalcitol	11	7.4	7.4
Nitrofurantoin (Monohydrate/Macrocrystals)	13	7.4	7.4
Olmesartan Medoxomil	27	7.2	7.2
Desoximetasone	14	7.0	7.0
Belimumab	23	6.9	6.9
Phenytoin	15	6.8	6.8
Sevelamer Carbonate	8	6.6	6.6
Triamcinolone Acetonide Ointment Usp, 0.05%	15	6.1	6.1
Zoledronic Acid	25	5.9	5.9
Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride And Dextrose	5	5.8	5.8
Naltrexone Hydrochloride And Bupropion Hydrochloride	5	5.5	5.5
Clobazam	14	5.4	5.4
Triamcinolone Acetonide	16	4.9	4.9
Cinacalcet Hydrochloride	24	4.9	4.9
Cenegermin-Bkbj	6	4.7	4.7
Abemaciclib	9	4.3	4.3
Isotretinoin	20	3.8	3.8
Lacosamide	15	3.8	3.8
Inclisiran	3	3.5	3.5
Ocrelizumab	23	3.5	3.5
Bosentan	18	3.4	3.4
Denosumab	69	3.3	3.3
Abaloparatide	10	3.2	3.2
Bictegravir Sodium, Emtricitabine, And Tenofovir Alafenamide Fumarate	4	2.1	2.1

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.